Published in Monoclonal Antibodies Weekly, January 26th, 2000
"Expression of the cell-surface oncofetal antigen, 5T4, is strongly associated with a wide spectrum of human cancers and is an excellent putative target for tumor-antigen targeted immunotherapy," wrote K. A. Myers and colleagues from Oxford BioMedica Ltd., and Paterson Institute for Cancer Research, England. "We have constructed a scFv derived from a monoclonal antibody specific for 5T4."
Data from their study was presented at the 7th Meeting of the European...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Monoclonal Antibodies Weekly